Search results

The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.

Researchers from the Health Research and Technology Group at ANSTO and the University of Wollongong have developed a new device that could improve the quality control of accelerator-based boron neutron capture therapy, a promising radiation therapy for treating aggressive cancers. 

Australia launched a new international development project in partnership with the International Atomic Energy Agency (IAEA) to advance ‘Rays of Hope’ in the Asia and Pacific region. 

2022 has been a big year for ANSTO with contributions to the advanced manufacturing, space, food, energy industries, and more. As we set our sights on 2023, we thought we’d take the opportunity to share some of our key innovation achievements from this year.

The National Deuteration Facility offers the facilities and expertise to produce molecules where all or part of the molecular hydrogen is replaced with deuterium. This enables complex investigations of the relationship between the structure of molecules and their function using neutron scattering and other techniques.

ANSTO groundwater experts have collaborated with the NSW Department of Planning, Industry and Environment on a comprehensive survey of groundwater resources in the state.

ANSTO environmental scientists have alerted the scientific community of the critical need to monitor changes to ice containing potential nuclear fallout that reached Antarctica from 20th century atmospheric weapons testing.

Combining scientific expertise with more than $1.3 billion in unique operational assets to provide optimal radioactive waste solutions.

ANSTO: Australia’s knowledge centre for nuclear science and engineering.

ANSTO provides trusted advice, training and consultancy services to Australia’s resource sector.